RU2130934C1 - Производные хинолина и хиназолина, способ их получения и фармацевтическая композиция - Google Patents

Производные хинолина и хиназолина, способ их получения и фармацевтическая композиция Download PDF

Info

Publication number
RU2130934C1
RU2130934C1 RU93004926A RU93004926A RU2130934C1 RU 2130934 C1 RU2130934 C1 RU 2130934C1 RU 93004926 A RU93004926 A RU 93004926A RU 93004926 A RU93004926 A RU 93004926A RU 2130934 C1 RU2130934 C1 RU 2130934C1
Authority
RU
Russia
Prior art keywords
group
quinoline
dimethoxy
carboxylic acid
dimethoxyphenyl
Prior art date
Application number
RU93004926A
Other languages
English (en)
Russian (ru)
Other versions
RU93004926A (ru
Inventor
Сохда Такаси
Макино Харухико
Баба Ацуо
Original Assignee
Такеда Кемикал Индастриз, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Такеда Кемикал Индастриз, Лтд. filed Critical Такеда Кемикал Индастриз, Лтд.
Publication of RU93004926A publication Critical patent/RU93004926A/ru
Application granted granted Critical
Publication of RU2130934C1 publication Critical patent/RU2130934C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C07D239/76—N-oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU93004926A 1992-04-24 1993-04-23 Производные хинолина и хиназолина, способ их получения и фармацевтическая композиция RU2130934C1 (ru)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
JP10642492 1992-04-24
JP106424/1992 1992-04-24
JP106424/92 1992-04-24
JP12188792 1992-05-14
JP121887/1992 1992-05-14
JP121887/92 1992-05-14
JP285865/92 1992-10-23
JP285865/1992 1992-10-23
JP28586592 1992-10-23
JP037952/1993 1993-02-26
JP3795293 1993-02-26

Publications (2)

Publication Number Publication Date
RU93004926A RU93004926A (ru) 1996-12-20
RU2130934C1 true RU2130934C1 (ru) 1999-05-27

Family

ID=27460501

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93004926A RU2130934C1 (ru) 1992-04-24 1993-04-23 Производные хинолина и хиназолина, способ их получения и фармацевтическая композиция

Country Status (14)

Country Link
US (1) US5948782A (enExample)
EP (1) EP0567107B1 (enExample)
KR (1) KR940005273A (enExample)
CN (1) CN1079222A (enExample)
AT (1) ATE209199T1 (enExample)
AU (1) AU656069B2 (enExample)
CA (1) CA2094774A1 (enExample)
DE (1) DE69331171T2 (enExample)
FI (1) FI931855L (enExample)
HU (2) HUT64322A (enExample)
NO (1) NO305973B1 (enExample)
NZ (1) NZ247477A (enExample)
RU (1) RU2130934C1 (enExample)
TW (1) TW232013B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455253A (en) * 1992-10-20 1995-10-03 Zeneca Limited Heterocyclic derivatives
KR100224135B1 (ko) * 1993-01-28 1999-10-15 다께다 구니오 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
ATE169924T1 (de) * 1993-05-18 1998-09-15 Takeda Chemical Industries Ltd Benzopyran-derivate und ihre verwendung
DE69422450T2 (de) * 1993-06-29 2000-06-08 Takeda Chemical Industries, Ltd. Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
CN1046270C (zh) * 1993-11-12 1999-11-10 法玛西雅厄普约翰美国公司 嘧啶－硫烷基或烷基醚化合物
WO1995024394A1 (en) * 1994-03-08 1995-09-14 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives as anti-inflammatory agents, in particular for treating arthritis
US5641788A (en) * 1994-06-07 1997-06-24 Takeda Chemical Industries, Ltd. Quinoline derivatives and pharmaceutical composition containing them
AU715358B2 (en) * 1995-04-28 2000-01-20 Takeda Chemical Industries Ltd. Therapeutic composition for arthritis
HUP9900169A2 (hu) * 1995-09-13 2000-03-28 Takeda Chemical Industries, Ltd. Immunoszuppresszáns hatású kinolin- vagy kinozalinszármazékok és ezeket tartalmazó gyógyászati készítmények
WO1999044612A1 (en) 1998-03-02 1999-09-10 Cocensys, Inc. Substituted quinazolines and analogs and the use thereof
US6184226B1 (en) * 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
WO2001042218A1 (en) * 1999-12-13 2001-06-14 Kabushiki Kaisha Toyota Chuo Kenkyusho Quinoline derivatives and organic electroluminescent devices
AR038658A1 (es) 2001-06-15 2005-01-26 Novartis Ag Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
US6620939B2 (en) 2001-09-18 2003-09-16 General Electric Company Method for producing bisphenol catalysts and bisphenols
AU2003219982A1 (en) * 2003-03-03 2004-09-28 General Electric Company Method for producing bisphenol catalysts and bisphenols
ZA200700599B (en) * 2004-06-25 2008-09-25 Sumitomo Chemical Co Method for producing (Z)-1-phenyl-1-diethylamino-carbonyl-2-hydroxymethyl cyclopropane
EA201270013A1 (ru) 2009-06-25 2012-06-29 Амген Инк. Гетероциклические соединения и их применение
WO2012046132A1 (en) 2010-10-05 2012-04-12 Purdue Pharma L.P. Quinazoline compounds as sodium channel blockers
AU2011329806A1 (en) * 2010-11-17 2013-05-30 Amgen Inc. Quinoline derivatives as PIK3 inhibitors
MX2015001099A (es) * 2012-08-24 2015-04-08 Hoffmann La Roche Nuevos derivados biciclicos de piridina.
CN105814022B (zh) * 2013-12-09 2018-09-28 Ucb生物制药私人有限公司 作为tnf活性调节剂的稠合的二环杂芳族衍生物

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU999966A3 (ru) * 1979-11-12 1983-02-23 Такеда Кемикал Индастриз (Фирма) Способ получени производных имидазола или их солей
EP0177764A1 (en) * 1984-09-07 1986-04-16 Kyowa Hakko Kogyo Co., Ltd. Quinoline-n-oxide derivative and pharmaceutical composition
EP0181568A2 (en) * 1984-10-30 1986-05-21 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-inflammatory/anti-allergic compounds
EP0402859B1 (en) * 1989-06-13 1993-01-20 Kyorin Pharmaceutical Co., Ltd. Therapeutic agents of metabolic bone disease
EP0339485B1 (en) * 1988-04-26 1993-03-31 The Du Pont Merck Pharmaceutical Company 4-quinoline carboxylic acid derivatives useful as immunosuppressive agents
EP0304063B1 (en) * 1987-08-20 1994-11-30 Nissan Chemical Industries Ltd. Quinoline type mevalonolactones
EP0354994B1 (en) * 1988-07-12 1995-01-25 Takeda Chemical Industries, Ltd. Quinoline derivatives, their production and use
EP0379145B1 (en) * 1989-01-17 1997-05-07 American Cyanamid Company Substituted quinolinecarboxylic acids

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2134169A1 (en) * 1971-04-23 1972-12-08 Clin Byla Ets 3-acyl-4-substd - quinoline derivs - analgesics, antiinflammatories, diuretics
DE3771153D1 (de) * 1986-09-12 1991-08-08 American Cyanamid Co Verfahren zur herstellung von pyridin-2,3-dicarboxylsaeuren.
GB8716971D0 (en) * 1987-07-17 1987-08-26 Pfizer Ltd Therapeutic agents
DE3935491A1 (de) * 1989-10-25 1991-05-02 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-carbonylharnstoffe
CA2080127A1 (en) * 1990-04-10 1991-10-11 Peter Zimmermann Pyridines as medicaments
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4129500A1 (de) * 1991-09-05 1993-03-11 Basf Ag Hochschlagzaehe, flammgeschuetzte polyphenylenether/polyamidformmassen
KR100224135B1 (ko) * 1993-01-28 1999-10-15 다께다 구니오 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU999966A3 (ru) * 1979-11-12 1983-02-23 Такеда Кемикал Индастриз (Фирма) Способ получени производных имидазола или их солей
EP0177764A1 (en) * 1984-09-07 1986-04-16 Kyowa Hakko Kogyo Co., Ltd. Quinoline-n-oxide derivative and pharmaceutical composition
EP0181568A2 (en) * 1984-10-30 1986-05-21 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-inflammatory/anti-allergic compounds
EP0304063B1 (en) * 1987-08-20 1994-11-30 Nissan Chemical Industries Ltd. Quinoline type mevalonolactones
EP0339485B1 (en) * 1988-04-26 1993-03-31 The Du Pont Merck Pharmaceutical Company 4-quinoline carboxylic acid derivatives useful as immunosuppressive agents
EP0354994B1 (en) * 1988-07-12 1995-01-25 Takeda Chemical Industries, Ltd. Quinoline derivatives, their production and use
EP0379145B1 (en) * 1989-01-17 1997-05-07 American Cyanamid Company Substituted quinolinecarboxylic acids
EP0402859B1 (en) * 1989-06-13 1993-01-20 Kyorin Pharmaceutical Co., Ltd. Therapeutic agents of metabolic bone disease

Also Published As

Publication number Publication date
HUT64322A (en) 1993-12-28
NO931482D0 (no) 1993-04-22
DE69331171D1 (de) 2002-01-03
TW232013B (enExample) 1994-10-11
KR940005273A (ko) 1994-03-21
EP0567107B1 (en) 2001-11-21
DE69331171T2 (de) 2002-07-11
NO931482L (no) 1993-10-25
HU9301197D0 (en) 1993-07-28
ATE209199T1 (de) 2001-12-15
HU211852A9 (en) 1995-12-28
AU3699193A (en) 1993-10-28
FI931855A7 (fi) 1993-10-25
EP0567107A1 (en) 1993-10-27
US5948782A (en) 1999-09-07
NZ247477A (en) 1995-07-26
FI931855A0 (fi) 1993-04-23
AU656069B2 (en) 1995-01-19
CN1079222A (zh) 1993-12-08
NO305973B1 (no) 1999-08-30
CA2094774A1 (en) 1993-10-25
FI931855L (fi) 1993-10-25

Similar Documents

Publication Publication Date Title
RU2130934C1 (ru) Производные хинолина и хиназолина, способ их получения и фармацевтическая композиция
KR100222309B1 (ko) 치환된 2-아실아미노-5-티아졸, 그의 제조방법 및 그것을 포함하는 약제학적 조성물
CN105960237B (zh) Ccr6化合物
SK27096A3 (en) Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids and pharmaceutical composition on their base
NO179868B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kondenserte heterocykliske forbindelser
US5945450A (en) Naphthalene derivative
WO2017198178A1 (zh) 噻唑类衍生物及其应用
NO147879B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-substituerte benzimidazoler
US9062061B2 (en) Compound having PARP inhibitory activity
PL119501B1 (en) Process for manufacturing novel,condensed pyrimidine derivatives pirimidina
CN102724975B (zh) IRE-1α抑制剂
US9624220B2 (en) Compounds and method for treatment of HIV
NO164351B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
US4442102A (en) 1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same
JPH09110866A (ja) 複素環式アリール−、アルキル−およびシクロアルキルアセトアミド類
WO1999054306A1 (en) Isoquinolinesulfonamide derivatives and drugs containing the same as the active ingredient
JP2648434B2 (ja) キノリンまたはキナゾリン誘導体を含有する医薬組成物
US4612317A (en) Tetrahydro-β-carboline dithioic acid derivatives and treatment of liver diseases
JP2794640B2 (ja) イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JPS6212757A (ja) 桂皮酸アミド誘導体
JPS6229585A (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置２で置換された４―ｏｈキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
JPH0753730B2 (ja) イミダゾピラゾール誘導体
CA2035988A1 (en) Imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediaes
CN102512421B (zh) 哌嗪酰胺类化合物在制药中的应用
CZ324997A3 (cs) 1-[omega-(3,4-Dihydro-2-naftalenyl)alkyl]cyklický amin, způsob jeho výroby, farmaceutický prostředek ho obsahující a činidlo pro léčení častého močení a močové inkontinence